Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Clinical trial NCT06391918 · TERMINATED

Trial details

NCT number: NCT06391918
Sponsor: GenVivo, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2024-03-04
Primary completion: 2026-03-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.